Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Experts line up best bets as Nifty, Sensex reach record highs

      Experts expect the rally to continue in the coming sessions, with the Nifty 50 moving towards 19,100-19,200 levels, after which minor profit booking can't be ruled out.

    • As bull run on D-Street continues, here are top 10 ideas for next 3-4 weeks

      This week, 18,650-18,700 is expected to be a crucial hurdle and, if the index decisively surpasses this area, then 18,800-19,000 levels can't be ruled out

    • Sideways trend may persist in Nifty, but these 3 stock ideas can return up to 10% in short term

      The ongoing sideways trend may persist until there is a decisive breakout above the 17,250 resistance level.

    • Top 10 trading ideas for next 3-4 weeks as experts see relief rally ahead of Budget

      Traders should keep focusing on stock-specific moves and should ideally remain light on positions till the time key indices consolidate in the recent congestion zone, Sameet Chavan of Angel One advised

    • Top 10 trading ideas for next 3-4 weeks as indices trade lower, headwinds linger

      Rising cases of Covid infection in several countries, fear of further tightening of key policy rates by the Federal Reserve, and a growth threat of recession-like situation pose challenges for markets around the world

    • Experts line up 10 stocks that may take part in Nifty's journey towards 19,000

      The momentum seems to be in favour of bulls but having consistent run-up for the last few days, some bouts of volatility and consolidation can be seen in coming sessions, before taking gradual march towards first 18,700-19,000 area

    • Sun Pharma’s specialty drugs bet is beginning to pay off

      Sun Pharmaceutical’s foray into specialty drugs was in some ways driven by an existential threat posed by rising competition to its generic drug business in the US. In the September quarter, it reported sales of $200 million from specialty drugs in the US, up 27.5 percent YoY

    • Hot Stocks | Here's why you should bet on Sun Pharma, Mphasis for the short term

      Technically speaking, Sun Pharma prices are continuing with higher highs and higher lows cycle and the way momentum oscillators are poised, we will not be surprised to see this stock entering the 4-digit territory soon.

    • Hot Stocks | Here is why you should bet on GMM Pfaudler, Sun Pharma in short term

      After a long bearish trend, the pharma indices have recovered from bottom and formed “Flag & Poll” pattern, which suggests bullish strength in pharma sector.

    • Top 10 trading ideas from experts for next 3-4 weeks as bulls hold fort

      Occurrence of a ‘Bullish Hammer’ on weekly scale near the confluence zone of a multi support area of its 200 week EMA reconfirm the strength of its ongoing channel support zone in Zensar Technologies. Trend strength indicator RSI too exhibits a positive crossover along with a likely trend break

    • Trade Spotlight | What should you do with Navin Fluorine, Tata Steel, Hatsun Agro and Sun Pharma?

      Trade Spotlight | Here's what Mazhar Mohammad of Chartviewindia.in recommends investors should do with these stocks when the market resumes trading today.

    • Trade Spotlight | What should investors do with Jindal Steel & Power, Sun Pharma, Trident?

      Here's what Shrikant Chouhan of Kotak Securities recommends investors should do with these stocks when the market resumes trading today.

    • Hot Stocks | Here's why you should buy ONGC and sell Sun Pharma for short term

      Traders can continue with a stock-specific approach and we may see trades on both sides if the Nifty remains in a consolidation mode.

    • Hot Stocks: 'Can bet on Sun Pharma, BHEL and Canara Bank for double-digit returns in 2-3 weeks'

      The key support levels to watch for in the short term are 17,531 (20-Day SMA) and 17,254 (3-Week Low), said Vidnyan Sawant of GEPL Capital,

    • Sensex, Nifty at historic highs | Experts suggest top 10 trading ideas for next 3-4 weeks

      Following the rally over the past one month, experts suggest that investors book timely profits and avoid aggressive buying. According to them, the next resistance on the Nifty 50 is expected at 18,000, with support at 17,600.

    • Nifty ready to move towards 17,500 | Top 10 trading ideas for next 3-4 weeks

      Experts said the momentum is expected to remain in the bulls’ basket but considering the hefty run-up until last week, some amount of profit-booking and consolidation can’t be ruled out

    • Nifty at fresh record high, pick these 14 attractively-valued stocks for portfolio

      Given the expected strong momentum, experts advise top 14 stock picks that are available at attractive valuations now

    • Hot Stocks | Can bet on Prakash Industries, Happiest Minds Technologies, Sun Pharma for short term

      The stocks from the cash segment did exceedingly well after a lull of nearly four weeks. It’s advisable to focus on such potential movers, said Angel Broking's Sameet Chavan

    • Nifty can fall to 14,200-14,300, buy these 3 stocks for up to 27% return

      The Benchmark index has seen 5 DMA and 10 DMA bearish crossover formations which are supportive for the continuation of bearish price movement further.

    • Nifty to test 15,700 in coming months; ICICI Direct handpicks over 20 bargain buys across sectors

      Markets buoyed by US Fed’s view that it would remain focused on getting people back to work as vaccines help the pandemic-hit economy recover.

    • Budget 2021 | Focus on healthcare but mixed bag for pharma, 9 stocks you can pick from sector

      The sector was in focus in Union Budget 2021. Finance Minister Nirmala Sitharaman in her Budget speech announced an outlay of Rs 2,23,846 crore for health and well being.

    • Union Budget 2021 likely to focus on infra, healthcare; analysts see these 10 stocks gaining

      D-Street is counting on key reforms in the Budget that could push growth and kicks tart the capex cycle in the economy.

    • 'Continue with buy on dip strategy, these 3 picks could return 10-20% in short term'

      Early signs of trend reversal will come on a close below the previous two day's low standing around 13,400.

    • Hot Stocks | Can bet on Aurobindo Pharma, Sun Pharma and Maharashtra Seamless for short term

      On the technical front, secondary oscillators suggest that markets are likely to remain volatile in the coming sessions with wild swings on both sides.

    • Hot Stocks | Here are three trading ideas for the short term

      The December derivatives series is 5-week long and volatility may increase if India VIX crosses 23 levels on the higher side.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347